Interleukin-6: A bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells

Autophagy

Volumn 8, Issue 4, 2012, Pages 650-663

  Delk, Nikki A ^a   Farach Carson, Mary C ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

Autophagy; Bone metastatic prostate cancer; Interleukin 6; Neuroendocrine differentiation; Paracrine signaling

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; LC3 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; BONE MARROW CELL; BONE MARROW STROMAL CELL; BONE METASTASIS; CANCER CELL; CELL PROTECTION; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE SEVERITY; HUMAN; HUMAN CELL; MALE; NEUROENDOCRINE DIFFERENTIATION; NEUROENDOCRINE SYSTEM; PARACRINE SIGNALING; PROSTATE CANCER; PROTEIN SECRETION; REGULATORY MECHANISM; TISSUE DIFFERENTIATION;

EID: 84862281540     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.19226     Document Type: Article

References (40)

1. Msaouel P, Pissimissis N, Halapas A, Koutsilieris M. Mechanisms of bone metastasis in prostate cancer: clinical implications. Best Pract Res Clin Endocrinol Metab 2008; 22:341-55; PMID:18471791; http://dx. doi.org/10.1016/j. beem.2008.01.011
2. Zhang C, Soori M, Miles FL, Sikes RA, Carson DD, Chung LW, et al. Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells. Prostate 2011; 71:157-67; PMID:20665531; http://dx.doi.org/10.1002/pros.21231
3. Roecklein BA, Torok-Storb B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 1995; 85:997-1005; PMID:7849321
4. Sun Y, Niu J, Huang J. Neuroendocrine differentiation in prostate cancer. Am J Transl Res 2009; 1:148-62; PMID:19956427
5. Marcu M, Radu E, Sajin M. Neuroendocrine transdifferentiation of prostate carcinoma cells and its prognostic significance. Rom J Morphol Embryol 2010; 51:7-12; PMID:20191113
6. Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, et al. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocr Relat Cancer 2006; 13:151-67; PMID: 16601285; http://dx.doi.org/10.1677/erc.1.01043
7. Cox ME, Deeble PD, Lakhani S, Parsons SJ. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res 1999; 59:3821-30; PMID:10447001
8. Kenific CM, Thorburn A, Debnath J. Autophagy and metastasis: another double-edged sword. Curr Opin Cell Biol 2010; 22:241-5; PMID:19945838; http://dx. doi.org/10.1016/j.ceb.2009.10.008
9. Mariño G, López-Otín C. Autophagy: molecular mechanisms, physiological functions and relevance in human pathology. Cell Mol Life Sci 2004; 61:1439-54; PMID:15197469; http://dx.doi.org/10.1007/s00018-004- 4012-4
10. White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15:5308-16; PMID:19706824; http://dx.doi. org/10.1158/1078-0432.CCR-07-5023
11. Lock R, Debnath J. Extracellular matrix regulation of autophagy. Curr Opin Cell Biol 2008; 20:583-8; PMID: 18573652; http://dx.doi.org/10.1016/j.ceb. 2008.05.002
12. Lee JA. Autophagy in neurodegeneration: two sides of the same coin. BMB Rep 2009; 42:324-30; PMID: 19558789; http://dx.doi.org/10.5483/BMBRep.2009. 42.6.324
13. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009; 43:67-93; PMID:19653858; http://dx.doi.org/ 10.1146/annurev-genet-102808-114910
14. Kabeya Y, Mizushima N, Yamamoto A, Oshitani- Okamoto S, Ohsumi Y, Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 2004; 117:2805-12; PMID:15169837; http://dx.doi.org/10.1242/jcs.01131
15. Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, et al. A ubiquitin-like system mediates protein lipidation. Nature 2000; 408:488-92; PMID:11100732; http://dx.doi.org/10.1038/35044114
16. Tanida I, Sou YS, Ezaki J, Minematsu-Ikeguchi N, Ueno T, Kominami E. HsAtg4B/HsApg4B/autophagin- 1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3- and GABAA receptor-associated protein-phospholipid conjugates. J Biol Chem 2004; 279:36268-76; PMID:15187094; http://dx.doi.org/10. 1074/jbc.M401461200
17. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007; 3:542-5; PMID: 17611390
18. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4:151-75; PMID: 18188003
19. Spiotto MT, Chung TD. STAT3 mediates IL-6- induced neuroendocrine differentiation in prostate cancer cells. Prostate 2000; 42:186-95; PMID: 10639189; http://dx.doi.org/10.1002/(SICI)1097-0045 (20000215)42:3,186::AID- PROS4.3.0.CO;2-E
20. Lee SO, Lou W, Johnson CS, Trump DL, Gao AC. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. Prostate 2004; 60:178-86; PMID:15176047; http://dx.doi.org/10.1002/pros.20045
21. Graf L, Iwata M, Torok-Storb B. Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a. Blood 2002; 100:1509-11; PMID:12184274; http://dx.doi. org/10.1182/blood-2002- 03-0844
22. Xu X, Kasembeli MM, Jiang X, Tweardy BJ, Tweardy DJ. Chemical probes that competitively and selectively inhibit Stat3 activation. PLoS One 2009; 4:e4783; PMID:19274102; http://dx.doi.org/10.1371/journal. pone.0004783
23. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994; 54:2577-81; PMID:8168083
24. Levine B. Cell biology: autophagy and cancer. Nature 2007; 446:745-7; PMID:17429391; http://dx.doi.org/10.1038/446745a
25. Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol 2010; 12:823-30; PMID:20811354; http://dx.doi.org/10. 1038/ncb0910-823
26. Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Pienta KJ. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem 2009; 284:34342-54; PMID:19833726; http://dx.doi.org/10.1074/jbc.M109.042671
27. Adler HL, McCurdy MA, Kattan MW, Timme TL, Scardino PT, Thompson TC. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol 1999; 161:182-7; PMID:10037394; http://dx.doi.org/10.1016/S0022-5347(01)62092-5
28. Drachenberg DE, Elgamal AA, Rowbotham R, Peterson M, Murphy GP. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate 1999; 41:127-33; PMID: 10477909; http://dx.doi.org/10.1002/ (SICI)1097-0045 (19991001)41:2<127::AID-PROS7>3.0.CO;2-H
29. Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 2001; 58:1008-15; PMID:11744478; http://dx.doi.org/10.1016/S0090-4295(01)01405-4
30. de Vernejoul MC, Cohen-Solal M, Orcel P. Bone cytokines. Curr Opin Rheumatol 1993; 5:332-8; PMID:8512770; http://dx.doi.org/10.1097/00002281- 199305030-00012
31. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002; 8:945-54; PMID:11948098
32. Weerasinghe P, Li Y, Guan Y, Zhang R, Tweardy DJ, Jing N. T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling. Prostate 2008; 68:1430-42; PMID:18615483; http://dx.doi. org/10.1002/pros.20807
33. Ni Z, Lou W, Leman ES, Gao AC. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res 2000; 60:1225-8; PMID:10728680
34. Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, et al. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Clin Cancer Res 2005; 11:6333-41; PMID:16144938; http://dx.doi.org/10.1158/1078-0432. CCR-05-0148
35. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010; 13:805-11; PMID:20581817; http://dx.doi.org/10.1038/nn.2575
36. Martinez-Vicente M, Cuervo AM. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 2007; 6:352-61; PMID:17362839; http://dx.doi.org/10.1016/S1474-4422(07)70076-5
37. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, et al. Macroautophagy - a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 2005; 171:87-98; PMID: 16203860; http://dx.doi.org/10.1083/jcb.200505082
38. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140:313-26; PMID:20144757; http://dx.doi.org/10.1016/j. cell. 2010.01.028
39. Zheng J, Yan T, Feng Y, Zhai Q. Involvement of lysosomes in the early stages of axon degeneration. Neurochem Int 2010; 56:516-21; PMID:20036294; http://dx.doi.org/10.1016/j.neuint.2009.12.012
40. Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007; 21:1396-408; PMID: 17510282; http://dx.doi.org/10.1101/gad.1553707